165 related articles for article (PubMed ID: 6413369)
1. Apheresis in hematologic and oncologic disease.
Cohen RJ
Hosp Pract (Off Ed); 1983 Oct; 18(10):199-205. PubMed ID: 6413369
[TBL] [Abstract][Full Text] [Related]
2. [Methods of plasmapheresis using blood fractionation devices].
Kalinin NN
Sov Med; 1989; (8):40-5. PubMed ID: 2683140
[No Abstract] [Full Text] [Related]
3. [Plasma-cytapheresis in patients and donors (prospects of Soviet-American cooperation].
Kalinin NN; Khester DP
Gematol Transfuziol; 1990 Mar; 35(3):26-30. PubMed ID: 2361584
[No Abstract] [Full Text] [Related]
4. Therapeutic plasma and cellular apheresis.
Urbaniak SJ
Clin Haematol; 1984 Feb; 13(1):217-51. PubMed ID: 6373082
[No Abstract] [Full Text] [Related]
5. [Problems in blood donors in plasmapheresis and cytopheresis].
Fiala J
Vnitr Lek; 1982 Feb; 28(2):182-8. PubMed ID: 7064373
[No Abstract] [Full Text] [Related]
6. Biotherapy with interferon in hematologic malignancies.
Roth MS; Foon KA
Oncol Nurs Forum; 1987; 14(6 Suppl):16-22. PubMed ID: 2447569
[No Abstract] [Full Text] [Related]
7. Plasmapheresis and paraproteinemia: cryoprotein-induced diseases, monoclonal gammopathy, Waldenström's macroglobulinemia, hyperviscosity syndrome, multiple myeloma, light chain disease, and amyloidosis.
Siami GA; Siami FS
Ther Apher; 1999 Feb; 3(1):8-19. PubMed ID: 10079800
[TBL] [Abstract][Full Text] [Related]
8. Therapeutic apheresis for the renal complications of multiple myeloma and the dysglobulinemias.
Kaplan AA
Ther Apher; 2001 Jun; 5(3):171-5. PubMed ID: 11467752
[TBL] [Abstract][Full Text] [Related]
9. Plasma exchange: a selective form of blood-letting.
Isbister JP
Med J Aust; 1979 Aug; 2(4):167-73. PubMed ID: 160005
[TBL] [Abstract][Full Text] [Related]
10. [Treatment of blood diseases in a specialized department].
Beran M; Carlmark B; Ehn L; Ericsson F; Forsberg K; Hast R; Höglund S; Lantz B; Pihlstedt P; Reizenstein P; Skårberg KO; Udén AM; Osby E
Lakartidningen; 1980 Apr; 77(17):1635-9. PubMed ID: 6770206
[No Abstract] [Full Text] [Related]
11. [Use of plasmapheresis in surgical hematology].
Abdulkadyrov KM; Shatrov VA; Katsadze IuL
Vestn Khir Im I I Grek; 1983 Oct; 131(10):125-8. PubMed ID: 6419431
[TBL] [Abstract][Full Text] [Related]
12. [Hemodilution and plasmapheresis in the therapy of hyperviscosity syndromes].
Di Lollo F; Fazzini G; Avanzi G
Ric Clin Lab; 1983; 13 Suppl 3():225-44. PubMed ID: 6424221
[TBL] [Abstract][Full Text] [Related]
13. Therapeutic leukapheresis in hairy cell leukemia.
Mielke CH; Dobbs CE; Winkler CF; Yam LT
Arch Intern Med; 1982 Apr; 142(4):700-2. PubMed ID: 7073413
[TBL] [Abstract][Full Text] [Related]
14. Therapeutic apheresis.
Taft EG
Hum Pathol; 1983 Mar; 14(3):235-40. PubMed ID: 6832771
[TBL] [Abstract][Full Text] [Related]
15. [Clinical use of plasmapheresis].
Del Favero A; Morelli A; Narducci F
Clin Ter; 1981 Jan; 96(1):93-9. PubMed ID: 6786819
[No Abstract] [Full Text] [Related]
16. Clinical relevance of fractionation characteristics in cascade filtration.
Busnach G; Mandelli E; Brando B; Brunati C
Int J Artif Organs; 1993 Dec; 16 Suppl 5():155-9. PubMed ID: 8013978
[TBL] [Abstract][Full Text] [Related]
17. Massive hollow fiber clotting: a distinct problem in treatment of cryoglobulinemia by membrane plasmapheresis.
Lai KN; Cheng SC; Vallance-Owen J
Artif Organs; 1987 Jun; 11(3):259-64. PubMed ID: 3113406
[TBL] [Abstract][Full Text] [Related]
18. [Plasmapheresis].
Speiser P
Wien Klin Wochenschr; 1967 Sep; 79(38):689-92. PubMed ID: 4969820
[No Abstract] [Full Text] [Related]
19. Plasma viscosity changes after sham plasmapheresis.
Jakoet A; Martell RW; Jacobs P
Lancet; 1987 Oct; 2(8566):1031-2. PubMed ID: 2889944
[No Abstract] [Full Text] [Related]
20. The use of emergency apheresis in the management of plasma cell disorders.
Kalayoglu-Besisik S
Transfus Apher Sci; 2018 Feb; 57(1):35-39. PubMed ID: 29477943
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
